Form 8-K - Current report:
SEC Accession No. 0001193125-24-192848
Filing Date
2024-08-02
Accepted
2024-08-02 16:03:53
Documents
13
Period of Report
2024-08-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d877890d8k.htm   iXBRL 8-K 29348
  Complete submission text file 0001193125-24-192848.txt   152537

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nexi-20240802.xsd EX-101.SCH 2501
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20240802_lab.xml EX-101.LAB 17945
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20240802_pre.xml EX-101.PRE 11228
16 EXTRACTED XBRL INSTANCE DOCUMENT d877890d8k_htm.xml XML 3750
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 241170890
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)